The age of blood evaluation (ABLE) randomised controlled trial: Description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up

Health Technology Assessment

Volumn 21, Issue 62, 2017, Pages 1-118

  Walsh, Timothy S ^a   Stanworth, Simon ^b,c,d   Boyd, Julia ^e   Hope, David ^f   Hemmatapour, Sue ^b   Burrows, Helen ^b   Campbell, Helen ^d   Pizzo, Elena ^g   Swart, Nicholas ^g   Morris, Stephen ^g  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; FOLLOW UP; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; MORTALITY; MULTIPLE ORGAN FAILURE; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STORAGE; UNITED KINGDOM; ADOLESCENT; ADULT; AGED; ARTIFICIAL VENTILATION; BLOOD STORAGE; CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL MORTALITY; LENGTH OF STAY; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESERVATION; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INFECTION; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RESPIRATION, ARTIFICIAL; UNITED KINGDOM; YOUNG ADULT;

EID: 85034060133     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta21620     Document Type: Article

References (74)

1. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006;20:273-82. https://doi.org/10.1016/ j.tmrv.2006.05.002
2. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 2015;350:h1354. https://doi.org/10.1136/bmj.h1354
3. Carson JL, Carless PA, Hébert PC. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 2013;309:83-4. https://doi.org/10.1001/jama.2012.50429
4. Carson JL, Carless PA, Hébert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012;10:CD002042. https://doi.org/ 10.1002/14651858.CD002042.pub3
5. D’Alessandro A, Liumbruno G, Grazzini G, Zolla L. Red blood cell storage: the story so far. Blood Transfus 2010;8:82-8.
6. Vamvakas EC. Meta-analysis of clinical studies of the purported deleterious effects of ‘old’ (versus ‘fresh’) red blood cells: are we at equipoise? Transfusion 2010;50:600-10. https://doi.org/10.1111/ j.1537-2995.2009.02465.x
7. Wilkinson KL, Brunskill SJ, Dorée C, Hopewell S, Stanworth S, Murphy MF, Hyde C. The clinical effects of red blood cell transfusions: an overview of the randomized controlled trials evidence base. Transfus Med Rev 2011;25:145-55.e2. https://doi.org/10.1016/j.tmrv.2010.11.006
8. Tinmouth A, Fergusson D, Yee IC, Hébert PC, ABLE Investigators. Clinical consequences of red cell storage in the critically ill. Transfusion 2006;46:2014-27. https://doi.org/10.1111/j.1537-2995. 2006.01026.x
9. Walsh TS, McArdle F, McLellan SA, Maciver C, Maginnis M, Prescott RJ, et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004;32:364-71. https://doi.org/10.1097/01.CCM. 0000108878.23703.E0
10. Hébert PC, Chin-Yee I, Fergusson D, Blajchman M, Martineau R, Clinch J, Olberg B. A pilot trial evaluating the clinical effects of prolonged storage of red cells. Anesth Analg 2005;100:1433-8. https://doi.org/10.1213/01.ANE.0000148690.48803.27
11. Napolitano LM, Kurek S, Luchette FA, Anderson GL, Bard MR, Bromberg W, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma 2009;67:1439-42. https://doi.org/10.1097/TA.0b013e3181ba7074
12. Walsh TS, Wyncoll DL, Stanworth SJ. Managing anaemia in critically ill adults. BMJ 2010;341:c4408. https://doi.org/10.1136/bmj.c4408
13. Walsh TS, Garrioch M, Maciver C, Lee RJ, MacKirdy F, McClelland DB, et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004;44:1405-11. https://doi.org/10.1111/j.1537-2995.2004.04085.x
14. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17. https://doi.org/10.1056/NEJM199902113400601
15. Lone NI, Gillies MA, Haddow C, Dobbie R, Rowan KM, Wild SH, et al. Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med 2016;194:198-208. https://doi.org/10.1164/rccm.201511-2234OC
16. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009;96:93-103. https://doi.org/10.1111/j.1423-0410.2008.01117.x
17. Lacroix J, Hébert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011;25:197-205. https://doi.org/10.1016/j.tmrv.2011.03.001
18. Heddle NM, Cook RJ, Arnold DM, Crowther MA, Warkentin TE, Webert KE, et al. The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial. Transfusion 2012;52:1203-12. https://doi.org/10.1111/j.1537-2995.2011.03521.x
19. Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013;41:2354-63. https://doi.org/10.1097/CCM.0b013e318291cce4
20. d’Almeida MS, Gray D, Martin C, Ellis CG, Chin-Yee IH. Effect of prophylactic transfusion of stored RBCs on oxygen reserve in response to acute isovolemic hemorrhage in a rodent model. Transfusion 2001;41:950-6. https://doi.org/10.1046/j.1537-2995.2001.41070950.x
21. d’Almeida MS, Jagger J, Duggan M, White M, Ellis C, Chin-Yee IH. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion. Transfus Med 2000;10:291-303. https://doi.org/10.1046/ j.1365-3148.2000.00267.x
22. Raat NJ, Verhoeven AJ, Mik EG, Gouwerok CW, Verhaar R, Goedhart PT, et al. The effect of storage time of human red cells on intestinal microcirculatory oxygenation in a rat isovolemic exchange model. Crit Care Med 2005;33:39-45. https://doi.org/10.1097/01.CCM.0000150655.75519.02
23. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229-39. https://doi.org/ 10.1056/NEJMoa070403
24. Middelburg RA, van de Watering LM, van der Bom JG. Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research. Transfusion 2010;50:1181-3. https://doi.org/10.1111/j.1537-2995.2010.02675.x
25. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269:3024-9. https://doi.org/10.1001/jama.1993.03500230106037
26. Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003;289:1941-9. https://doi.org/10.1001/jama.289.15.1941
27. Great Britain. Mental Capacity Act 2005. London: The Stationery Office; 2005.
28. Great Britain. Adults with Incapacity (Scotland) Act 2000. Edinburgh: Scottish Government; 2000.
29. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208. https://doi.org/10.1016/0168-8510(90)90421-9
30. Devlin N, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England. 2016. URL: eprints.whiterose.ac.uk/97964/ (accessed 26 July 2016).
31. Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, et al. Age of transfused blood in critically ill adults. N Engl J Med 2015;372:1410-18. https://doi.org/10.1056/NEJMoa1500704
32. NICE. Guide to the Methods of Technology Appraisal. London: NICE; 2013.
33. Curtis L, Burns A. Unit Costs of Health and Social Care. Canterbury: PSSRU, University of Kent; 2015.
34. Campbell HE, Stokes EA, Bargo DN, Curry N, Lecky FE, Edwards A, et al. Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England. Crit Care 2015;19:276. https://doi.org/10.1186/s13054-015-0987-5
35. Department of Health. NHS Reference Costs 2015 to 2016. London: Department of Health; 2016.
36. Curtis L. Unit Costs of Health and Social Care. Canterbury: PSSRU, University of Kent; 2013.
37. NHS. Blood and Transplant Price List 2014-15. London: NHS; 2015.
38. National Insitute for Health and Care Excellence (NICE). Sepsis: Recognition, Diagnosis and Early Management. NICE guideline [NG51]. London: NICE; 2016.
39. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72. https://doi.org/10.1016/ 0168-8510(96)00822-6
40. Improve Trial Investigators. Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: one-year outcomes from the IMPROVE randomized trial. Eur Heart J 2015;36:2061-9. https://doi.org/10.1093/eurheartj/ehv125
41. Szende A, Oppe M, Devlin N. EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Rotterdam: Springer; 2007. https://doi.org/10.1007/1-4020-5511-0
42. Briggs A, Clark T, Wolstenholme J, Clarke P. Missing…. presumed at random: cost-analysis of incomplete data. Health Econ 2003;12:377-92. https://doi.org/10.1002/hec.766
43. Briggs AH. Handling uncertainty in cost-effectiveness models. PharmacoEconomics 2000;17:479-500. http://dx.doi.org/10.2165/00019053-200017050-00006
44. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18(Suppl 2):68-80. https://doi.org/10.1177/ 0272989X98018002S09
45. Angus DC, Carlet J, 2002 Brussels Roundtable Participants. Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med 2003;29:368-77. https://doi.org/10.1007/ s00134-002-1624-8
46. Harrison DA, Prabhu G, Grieve R, Harvey SE, Sadique MZ, Gomes M, et al. Risk Adjustment In Neurocritical care (RAIN)-prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study. Health Technol Assess 2013;17(23). http://dx.doi.org/10.3310/ hta17230
47. Harvey SE, Parrott F, Harrison DA, Sadique MZ, Grieve RD, Canter RR, et al. A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients (CALORIES). Health Technol Assess 2016;20(28). http://dx.doi.org/10.3310/hta20280
48. Hernández RA, Jenkinson D, Vale L, Cuthbertson BH. Economic evaluation of nurse-led intensive care follow-up programmes compared with standard care: the PRaCTICaL trial. Eur J Health Econ 2014;15:243-52. https://doi.org/10.1007/s10198-013-0470-7
49. Feng Y, Devlin N, Herdman M. Assessing the health of the general population in England: how do the three-and five-level versions of EQ-5D compare? Health Qual Life Outcomes 2015;13:171. https://doi.org/10.1186/s12955-015-0356-8
50. Ferreira LN, Ferreira PL, Ribeiro FP, Pereira LN. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Health Qual Life Outcomes 2016;14:89. https://doi.org/ 10.1186/s12955-016-0491-x
51. Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population. Health Qual Life Outcomes 2014;12:74. https://doi.org/10.1186/1477-7525-12-74
52. Greene ME, Rader KA, Garellick G, Malchau H, Freiberg AA, Rolfson O. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty. Clin Orthop Relat Res 2015;473:3383-90. https://doi.org/10.1007/s11999-014-4091-y
53. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22:1717-27. https://doi.org/10.1007/s11136-012-0322-4
54. Jia YX, Cui FQ, Li L, Zhang DL, Zhang GM, Wang FZ, et al. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Qual Life Res 2014;23:2355-63. https://doi.org/10.1007/ s11136-014-0670-3
55. Kim SH, Kim HJ, Lee SI, Jo MW. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res 2012;21:1065-73. https://doi.org/10.1007/ s11136-011-0018-1
56. Pan CW, Sun HP, Wang X, Ma Q, Xu Y, Luo N, Wang P. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Qual Life Res 2015;24:1767-74. https://doi.org/10.1007/s11136-014-0902-6
57. Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes 2015;13:14. https://doi.org/ 10.1186/s12955-014-0203-3
58. Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, et al. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res 2013;22:1707-16. https://doi.org/10.1007/s11136-012-0318-0
59. Yfantopoulos JN, Chantzaras AE. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. Eur J Health Econ 2017;18:519-31. http://dx.doi.org/ 10.1007/s10198-016-0807-0
60. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108. https://doi.org/ 10.1097/00005650-199711000-00002
61. Lone NI, Seretny M, Wild SH, Rowan KM, Murray GD, Walsh TS. Surviving intensive care: a systematic review of healthcare resource use after hospital discharge. Crit Care Med 2013;41:1832-43. https://doi.org/10.1097/CCM.0b013e31828a409c
62. Gruenberg DA, Shelton W, Rose SL, Rutter AE, Socaris S, McGee G. Factors influencing length of stay in the intensive care unit. Am J Crit Care 2006;15:502-9.
63. Hill AD, Fowler RA, Pinto R, Herridge MS, Cuthbertson BH, Scales DC. Long-term outcomes and healthcare utilization following critical illness-a population-based study. Critical Care 2016;20:76. https://doi.org/10.1186/s13054-016-1248-y
64. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004;9:197-204. https://doi.org/10.1258/1355819042250249
65. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987. https://doi.org/10.1002/9780470316696
66. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol 2013;160:445-64. https://doi.org/10.1111/bjh.12143
67. Klein AA, Arnold P, Bingham RM, Brohi K, Clark R, Collis R, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016;71:829-42. https://doi.org/ 10.1111/anae.13489
68. Vainiola T, Pettilä V, Roine RP, Räsänen P, Rissanen AM, Sintonen H. Comparison of two utility instruments, the EQ-5D and the 15D, in the critical care setting. Intensive Care Med 2010;36:2090-3. https://doi.org/10.1007/s00134-010-1979-1
69. Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012;52:1184-95. https://doi.org/10.1111/j.1537-2995.2011.03466.x
70. Lelubre C, Vincent JL. Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: a systematic review. Crit Care 2013;17:R66. https://doi.org/ 10.1186/cc12600
71. Brunskill SJ, Wilkinson KL, Doree C, Trivella M, Stanworth S. Transfusion of fresher versus older red blood cells for all conditions. Cochrane Database Syst Rev 2015;5:CD010801. https://doi.org/ 10.1002/14651858.CD010801.pub2
72. Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015;372:1419-29. https://doi.org/ 10.1056/NEJMoa1414219
73. Heddle NM, Cook RJ, Arnold DM, Liu Y, Barty R, Crowther MA, et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med 2016;375:1937-45. https://doi.org/10.1056/NEJMoa1609014
74. Kaukonen KM, Bailey M, Ady B, Aubron C, French C, Gantner D, et al. A randomised controlled trial of standard transfusion versus fresher red blood cell use in intensive care (TRANSFUSE): protocol and statistical analysis plan. Crit Care Resusc 2014;16:255-61.